Voices of children and adolescents on phase 1 or phase 2 cancer trials: A new trial endpoint?

about

Voices of children and adolescents on phase 1 or phase 2 cancer trials: A new trial endpoint?

Item

http://www.wikidata.org/entity/Q47559320

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Voices of children and adolesc ...... trials: A new trial endpoint?

@en

Voices of children and adolesc ...... trials: A new trial endpoint?

@nl

type

Item

label

Voices of children and adolesc ...... trials: A new trial endpoint?

@en

Voices of children and adolesc ...... trials: A new trial endpoint?

@nl

prefLabel

Voices of children and adolesc ...... trials: A new trial endpoint?

@en

Voices of children and adolesc ...... trials: A new trial endpoint?

@nl

P1476

Voices of children and adolesc ...... trials: A new trial endpoint?

@en

P2093

Catherine Fiona Macpherson

http://www.w3.org/2001/XMLSchema#string

Claire M Wharton

http://www.w3.org/2001/XMLSchema#string

Emily Dunn Stern

http://www.w3.org/2001/XMLSchema#string

Heather E Gross

http://www.w3.org/2001/XMLSchema#string

Holly J Meany

http://www.w3.org/2001/XMLSchema#string

Jichuan Wang

http://www.w3.org/2001/XMLSchema#string

Ruthanna Okorosobo

http://www.w3.org/2001/XMLSchema#string

Shana Jacobs

http://www.w3.org/2001/XMLSchema#string

Yao Iris Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 2 trial of recombinant tumor necrosis factor-alpha in combination with dactinomycin in children with recurrent Wilms tumor.

Methods for assessing responsiveness: a critical review and recommendations.

Decision making by parents of children with incurable cancer who opt for enrollment on a phase I trial compared with choosing a do not resuscitate/terminal care option

Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group

Patterns of symptoms and functional impairments in children with cancer.

Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method.

Patient-reported outcomes in end-of-life research in pediatric oncology.

Measuring fatigue for children with cancer: development and validation of the pediatric Functional Assessment of Chronic Illness Therapy-Fatigue (pedsFACIT-F).

P304

3799-3806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.30782

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Pamela S. Hinds

P577

2017-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28581685

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

phase II clinical trial

P932

5610606

http://www.w3.org/2001/XMLSchema#string